Privium Fund Management B.V. Ionis Pharmaceuticals Inc Transaction History
Privium Fund Management B.V.
- $401 Million
- Q3 2024
A detailed history of Privium Fund Management B.V. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Privium Fund Management B.V. holds 250,744 shares of IONS stock, worth $9.55 Million. This represents 2.51% of its overall portfolio holdings.
Number of Shares
250,744
Previous 247,267
1.41%
Holding current value
$9.55 Million
Previous $11.8 Million
14.77%
% of portfolio
2.51%
Previous 3.33%
Shares
10 transactions
Others Institutions Holding IONS
# of Institutions
403Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$574 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$540 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$393 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$333 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$300 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...